Healio Cardiac/Vascular Intervention
Cardiology Today Intervention aims to be the go-to resource for interventional cardiologists seeking practical information. This publication offers well-rounded coverage of key clinical trials and studies, essential practice management topics, and the latest advancements in interventional cardiology. It also focuses on specific areas such as coronary, peripheral, carotid, cerebrovascular, and structural procedures. The editorial team collaborates with top experts in the field to create valuable content that tackles the most pressing issues faced by interventional cardiologists today. With this objective in mind, the publication provides timely, credible, and feature-rich articles, highlighting innovative tips and techniques, as well as case studies and clinical insights.
Outlet metrics
Global
#63194
United States
#20669
Health/Health
#493
Articles
-
2 days ago |
healio.com | Gabrielle Capaldo
Key takeaways: Abdominal fat was more strongly associated with psoriasis risk compared with overall body fat. The findings suggest a need to expand treatment focus beyond the skin. Abdominal obesity is a greater risk factor for psoriasis than total body fat, according to an analysis of imaging data, suggesting clinicians should consider treatments that also reduce cardiometabolic risk.
-
2 days ago |
healio.com | Jennifer Southall
Key takeaways: Significantly fewer Hispanic patients received preferred first-line treatment for CLL vs. white patients. Use of preferred first-line treatment also varied by practice type. CHICAGO — Researchers observed inequities in receipt of first-line preferred therapies among a cohort of patients with chronic lymphocytic leukemia, according to results of a retrospective observational study.
-
2 days ago |
healio.com | Jennifer Southall
Key takeaways: Patients assigned liso-cel achieved longer median PFS and OS compared with standard of care. ORR was significantly higher with liso-cel vs. standard of care. CHICAGO — Lisocabtagene maraleucel significantly improved responses rates and survival outcomes among patients with relapsed or refractory chronic lymphocytic leukemia, according to findings presented at ASCO Annual Meeting.
-
3 days ago |
healio.com | Matthew Shinkle
Key takeaways: Adding niraparib to abiraterone acetate and prednisone lowered risk for cancer growth by 37% among certain patients with prostate cancer. Patients with BRCA1/2 mutations had a 48% risk reduction. CHICAGO — Adding niraparib to abiraterone acetate and prednisone may help slow cancer growth for patients with metastatic castration-sensitive prostate cancer with homologous recombination repair gene alterations.
-
3 days ago |
healio.com | Emma Bascom
Key takeaways: CMS is rescinding a Biden administration-era policy on abortion care for women in medical emergencies. Experts told Healio about the legal and ethical implications for providers. CMS announced that it is rescinding guidance directing U.S. hospitals to provide abortion care when necessary for pregnant patients experiencing medical emergencies. In July 2022 — just after Roe v.
Healio Cardiac/Vascular Intervention journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →